Harvard Bioscience, Inc. (FRA:HBI)
0.610
+0.005 (0.83%)
At close: Dec 4, 2025
-70.10% (1Y)
| Market Cap | 27.63M |
| Revenue (ttm) | 74.47M |
| Net Income (ttm) | -45.88M |
| Shares Out | n/a |
| EPS (ttm) | -1.04 |
| PE Ratio | n/a |
| Forward PE | 8.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 2,132 |
| Open | 0.610 |
| Previous Close | 0.605 |
| Day's Range | 0.610 - 0.610 |
| 52-Week Range | 0.214 - 2.180 |
| Beta | n/a |
| RSI | 56.21 |
| Earnings Date | Mar 6, 2026 |